F230. COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY

por Mathews, Maju, Gopal, Srihari, Singh, Arun, Gogate, Jagadish, Kim, Edward, Pungor, Katalin
Publicado 2018

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study

por Gopal, Srihari, Gogate, Jagadish, Pungor, Katalin, Kim, Edward, Singh, Arun, Mathews, Maju
Publicado 2020

Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks’ Treatment in Patients with Clinically Stable Schizophrenia

por Lambert, Martin, Sanchez, Pedro, Bergmans, Paul, Gopal, Srihari, Mathews, Maju, Wooller, Annette, Pungor, Katalin
Publicado 2020

Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes

por Pungor, Katalin, Bozikas, Vasilis P., Emsley, Robin, Llorca, Pierre-Michel, Gopal, Srihari, Mathews, Maju, Wooller, Annette, Bergmans, Paul
Publicado 2020

T45. A COMPARISON OF SCHIZOPHRENIA RELAPSE RATES OF 3 PALIPERIDONE FORMULATIONS, ONCE-DAILY, ONCE-MONTHLY AND ONCE EVERY-3-MONTH: POST-HOC ANALYSIS FROM 3 RANDOMIZED CONTROLLED TRI...

por Mathews, Maju, Gopal, Srihari, Singh, Arun, Nuamah, Isaac, Quinn, Anne Marie, Pungor, Katalin, Tan, Wilson, Soares, Bernardo, Kim, Edward
Publicado 2018

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Ho...

por Mathews, Maju, Gopal, Srihari, Singh, Arun, Nuamah, Isaac, Pungor, Katalin, Tan, Wilson, Soares, Bernardo, Kim, Edward, Savitz, Adam J
Publicado 2020

The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administ...

por Pungor, Katalin, Sanchez, Pedro, Pappa, Sofia, Attal, Jerome, Leopold, Karolina, Steegen, Geertje, Vita, Antonio, Marsella, Carol, Verrijcken, Caroline, Lahaye, Marjolein, Wooller, Annette
Publicado 2021

Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Databa...

por Li, Gang, Keenan, Alexander, Daskiran, Mehmet, Mathews, Maju, Nuamah, Isaac, Orman, Camille, Joshi, Kruti, Singh, Arun, Godet, Annabelle, Pungor, Katalin, Gopal, Srihari
Publicado 2021

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

por Garcia-Portilla, Maria Paz, Llorca, Pierre-Michel, Maina, Giuseppe, Bozikas, Vasilis P., Devrimci-Ozguven, Halise, Kim, Sung-Wan, Bergmans, Paul, Usankova, Irina, Pungor, Katalin
Publicado 2020